NCT05798455View on ClinicalTrials.gov

Evaluation of the Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Advanced Renal Cell Carcinoma

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 22, 2023

Primary Completion Date

May 22, 2025

Study Completion Date

May 22, 2026

Conditions
Renal Cell Carcinoma
Interventions
DRUG

Sodium Pentaborate

Capsules containing sodium pentaborate pentahydrate 500, 1000 and 1500 mg

Trial Locations (1)

5166614766

Imam Reza hospital and Clinic of Salamat, Tabriz

All Listed Sponsors
lead

Tabriz University of Medical Sciences

OTHER

NCT05798455 - Evaluation of the Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Advanced Renal Cell Carcinoma | Biotech Hunter | Biotech Hunter